- Home
- ARHS vs CYRX Comparison
ARHS vs CYRX Comparison
Compare ARHS & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARHS | CYRX |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 956.8M | 774.7M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ARHS | CYRX |
|---|---|---|
| Price | $9.66 | $14.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $10.78 | ★ $13.31 |
| AVG Volume (30 Days) | ★ 1.5M | 609.8K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $1,379,222,000.00 | $176,177,000.00 |
| Revenue This Year | $7.23 | $11.06 |
| Revenue Next Year | $7.10 | $8.45 |
| P/E Ratio | $32.17 | ★ N/A |
| Revenue Growth | ★ 8.51 | N/A |
| 52 Week Low | $5.57 | $7.61 |
| 52 Week High | $12.93 | $16.89 |
Technical Indicators
Market Signals| Indicator | ARHS | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.23 | 44.12 |
| Support Level | $7.28 | $14.60 |
| Resistance Level | $10.35 | $16.76 |
| Average True Range (ATR) | 0.52 | 0.64 |
| MACD | 0.21 | -0.10 |
| Stochastic Oscillator | 85.32 | 21.59 |
Price Performance
Historical ComparisonAbout ARHS Arhaus Inc.
Arhaus Inc is a growing lifestyle brand and omnichannel retailer of premium home furniture. The company offers merchandise in several categories, including furniture, outdoor, lighting, textiles, and decor through its Retail and e-commerce sales channels.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.